Sanara MedTech Inc.
SMTI
$20.76
$0.391.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.33M | 25.83M | 23.43M | 26.31M | 21.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.33M | 25.83M | 23.43M | 26.31M | 21.67M |
| Cost of Revenue | 1.87M | 1.94M | 1.84M | 2.25M | 1.99M |
| Gross Profit | 24.46M | 23.89M | 21.60M | 24.06M | 19.68M |
| SG&A Expenses | 19.88M | 21.55M | 21.44M | 21.89M | 17.42M |
| Depreciation & Amortization | 610.90K | 1.11M | 1.12M | 1.10M | 696.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.39M | 25.86M | 25.51M | 27.66M | 20.89M |
| Operating Income | 2.94M | -31.30K | -2.08M | -1.35M | 778.50K |
| Income Before Tax | 834.50K | -2.02M | -3.53M | -1.70M | -180.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 834.50K | -2.02M | -3.53M | -1.70M | -180.50K |
| Earnings from Discontinued Operations | -31.25M | -- | -- | -- | -2.68M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00K | 4.00K | 200.00 | 162.00K | 1.70K |
| Net Income | -30.41M | -2.01M | -3.53M | -1.54M | -2.86M |
| EBIT | 2.94M | -31.30K | -2.08M | -1.35M | 778.50K |
| EBITDA | 3.61M | 1.08M | -955.60K | -249.90K | 1.88M |
| EPS Basic | -3.52 | -0.23 | -0.41 | -0.18 | -0.34 |
| Normalized Basic EPS | 0.06 | -0.15 | -0.26 | -0.18 | -0.01 |
| EPS Diluted | -3.40 | -0.23 | -0.41 | -0.18 | -0.34 |
| Normalized Diluted EPS | 0.06 | -0.15 | -0.26 | -0.18 | -0.01 |
| Average Basic Shares Outstanding | 8.65M | 8.61M | 8.57M | 8.53M | 8.52M |
| Average Diluted Shares Outstanding | 8.94M | 8.61M | 8.57M | 8.53M | 8.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |